(S)-Equol 99%

(S)-Equol 99%: Ultra-Pure Isoflavone Metabolite for Women's Health Applications

Hefei Fushan Yuansheng Biotechnology Co., Ltd. offers pharmaceutical grade (S)-Equol 99%, a chiral-pure isoflavone metabolite with great bioactivity for menopause health formulations. Our white crystalline powder with purity ≥99% by HPLC. We have reliable manufacturing capability for bulk orders from 1kg to 500kg. This substance overcomes the “non-producer limitation” seen in 65-80% of individuals who don’t have the gut bacteria to naturally generate equol, since it is the only physiologically active enantiomer. 13+ years of functional nutrition and FDA GRAS-compliant production. We provide constant quality to USP criteria for bone health supplements, hormone balancing formulas and dermatological applications.

What Makes (S)-Equol Different from Standard Soy Isoflavones?

Most soy extracts include daidzein which has to be converted by the intestines, but only 20-35% of people have the bacteria Slackia isoflavoniconvertens essential to do this metabolic conversion. (S)-Equol 99% circumvents this biological variability by delivering the end active metabolite directly.

The (S)-enantiomer showed 13-fold more binding affinity for the Oestrogen Receptor Beta (ERβ) than the (R)-enantiomer. This selectivity allows for selective control of hormone activity, avoiding overstimulation of conventional oestrogen pathways. Clinical validation has shown that 10mg daily dosages lead to a substantial reduction in hot flashes, nite sweats, and shoulder stiffness in postmenopausal non-producers within 8-12 weeks.

Crystalline form enables thermal stability up to 180°C after encapsulation procedure however UV protection packaging is still critical for the assay integrity over 24 month shelf life.

(S)-Equol 99% Specifications

Clinical Applications Validated by Research

Menopausal Symptom Management

Women beyond menopause who take 10mg daily report a 40-50% decrease in their vasomotor symptoms like hot flashes and anxiety. Effects are stronger in non-equol producers, in whom endogenous synthesis cannot occur. (S)-Equol 99% provides selective receptor modulation and is less likely to stimulate breast tissue than hormone replacement therapy (HRT).

Bone Density Preservation

12 month intake of 10mg daily resulted in an 18-22% reduction in deoxypyridinoline (DPD) bone resorption indicators. The result is increased calcium retention and collagen cross-linking due to ERβ activation in osteoblasts. Our substance is combined with Vitamin D3 and K2 to help prevent osteoporosis in formulations for synergistic skeletal support.

Joint and Muscle Comfort

The 10 mg and 20 mg doses relieve musculoskeletal pain by improving microcirculation in synovial tissues. Better results in comparison studies over generic soy isoflavones due to direct absorption avoiding liver first-pass processing.

Manufacturing Excellence and Quality Assurance

Our supply chain includes GMP certified extraction facilities and ISO22000 compliant processing units to ensure batch to batch uniformity. Chiral HPLC analysis shows enantiomeric purity >99% which is important for preventing contamination with inactive (R)-isomer.

Headspace Gas Chromatography Residual solvent testing indicates that ethanol and methanol are present at levels below ICH Q3C Class II limits. Heavy metals profile is below the limits of USP guidelines and lead levels are continuously below 0.3ppm throughout manufacturing runs.

Microbial validation involves absence of E. coli, Salmonella and S. aureus as per AOAC methods. Each shipment is accompanied by a Certificate of Analysis (CoA) that includes 15+ quality parameters for ease of regulatory submission.

Formulation Strategies for Optimal Bioavailability

The lipophilic character of product (logP = 3.2) requires sophisticated administration mechanisms for water based supplements. Self-emulsifying pharmaceutical delivery systems (SEDDS) containing medium chain triglycerides are used to increase absorption rates 3-4 times over typical powder mixes.

Co-processing with phospholipids or β-cyclodextrin for tablet formulations offers superior dissolving characteristics and stability under accelerated ageing conditions (40°C/75% RH). Softgel encapsulation with vitamin E inhibits oxidative degradation of phenolic hydroxyl groups during storage for 24 months.

For transdermal penetration, anti-aging serums need to be topically applied at concentrations of 0.5-1.0% in emulsion systems buffered to pH 5.5-6.5. Antioxidant synergy in cosmeceutical matrices including coenzyme Q10 or resveratrol.

Why Partner With Hefei Fushan Yuansheng Biotechnology?

Our 54-patent portfolio includes proprietary stabilization technologies preserving chiral purity during manufacturing scale-up. The PhD-led R&D team provides formulation consultation, helping you navigate dosage optimization and combination ingredient selection.

Flexible order quantities from sample batches to multi-ton contracts accommodate startups and established brands alike. Regulatory support includes pre-submission CoA reviews and stability data sharing for NDI notifications or novel food applications.

With 13 years specializing in Nrf2 pathway research and molecular nutrition, we understand the science behind your product claims. Our evidence-based approach aligns with Google's E-E-A-T standards, ensuring your marketing narratives withstand scrutiny.

Frequently Asked Questions

Q:Who should consider (S)-Equol supplementation?

A:Menopausal women experiencing hot flashes, bone density concerns, or those genetically lacking equol-producing gut bacteria benefit most. Individuals with soy allergies or estrogen-dependent tumors should avoid usage. Pregnant women must not consume this ingredient.

Q:How quickly do effects become noticeable?

A:Clinical improvements in mood and energy appear within 4-6 weeks at 10mg daily dosing. Bone density markers require minimum 12-week assessment periods. Consistency matters—continuous supplementation for 8-12 weeks yields optimal outcomes.

Q:Does purity level impact efficacy?

A:Absolutely. Lower-purity grades (80-90%) contain inactive daidzein and genistein that compete for receptor binding sites. Our 99% specification eliminates this interference, ensuring predictable dose-response relationships in formulations.

Q:What certifications support regulatory compliance?

A:Our product meets China New Food Raw Material standards, FDA GRAS requirements, and USP monograph criteria. HALAL certification accommodates diverse market needs. Documentation packages include safety dossiers and stability studies for global market entries.

Q:Can it be combined with other active ingredients?

A:Yes. Synergistic formulations pair product with calcium citrate for bone health, or ashwagandha for stress-related menopausal symptoms. Avoid concurrent use with tamoxifen or aromatase inhibitors without medical supervision due to potential receptor interactions.

Request Your Sample and Technical Data Package

Discover how (S)-Equol 99% elevates your women's health product line. Contact our team at info@extrabroc.com for sample requests, pricing quotations, or technical consultations today.